Health Canada approves Moderna’s mRNA RSV vaccine, company saysThe company says it expects the RSV vaccine—called mRESVIA—to be available in early 2025. MS Symptoms: muscle weaknessIn this ongoing series, Nancy Banoub examines the symptoms of MS, their cause and outlines potential remedial steps that can be taken to help mitigate these symptoms. Feel free to share with patients. Overuse of oral corticosteroids is common among Canadian patients with severe asthma Frequent or prolonged OCS use can pose substantial health risks, but there are other options for severe asthma. Drug News—September 2024 A review of new launches, new indications, new dosage forms and Health Canada advisories. NEW DRUG: Quillivant ER for ADHD Get the info you need on this new product, part of our drug news roundup for September. Co-administering RSV and influenza vaccines to seniors is safe: European research Co-administration poses no health risk and does not impair immune response, according to a new randomized trial. Clinical challenges: fibromyalgia (part two) Three case reports to illustrate some of the more common characteristics of this ailment. NACI issues Canadian guidance for use of RSV vaccines in older adults The risk of severe respiratory syncytial virus (RSV) disease increases with age and with certain medical conditions. Exposomics 101: Environmental impacts on health This emerging area of study looks at the totality of environmental exposures we encounter throughout our lifetime and how these interact with our genetics to influence our health. Why the Canadian Immunization Guide should be our first stop for vaccination decision-making Vaccinations are an important—but not the only—component of any travel consultation. First Previous 1 2 3 4 5 Next Last
